Bidzina Kulumbegov says Pfizer vaccine remains critical to reducing severe disease and death

Allergist/Immunologist Bidzina Kulumbgov says in his Facebook post that Pfizer's effectiveness against the Omicron coronavirus variant has reduced 40% but its protection level against hospitalization and death remains high.

''Get your jabs,'' Kulumbegov says.